RecruitingPhase 1NCT06014905

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

Studying Meningioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Javier Villaneuva-Meyer, MD
Principal Investigator
Javier Villanueva-Meyer, MD, MD, PHD
University of California, San Francisco
Intervention
Hyperpolarized carbon C 13 pyruvate(drug)
Enrollment
50 enrolled
Eligibility
18 years · All sexes
Timeline
20232026

Study locations (1)

Collaborators

National Institute for Biomedical Imaging and Bioengineering (NIBIB) · General Electric · National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06014905 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma

← Back to all trials